Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Sieg

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
RSC Advances|January 30, 2026
Chromatography's evolution, unlocking affinity's new solution: potential-controlled affinity membrane chromatographyTobias Steegmüller, Maeliss Nzokam, Christian Sieg, et al.
ACS Chemical Biology|October 10, 2017
Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14Marion Schuller, Kerstin Riedel, Ian Gibbs-Seymour, et al.
British Journal of Pharmacology|April 6, 2017
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approachAli Ryan, Elena Polycarpou, Nathan A Lack, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
RSC Advances|January 30, 2026
Chromatography's evolution, unlocking affinity's new solution: potential-controlled affinity membrane chromatographyTobias Steegmüller, Maeliss Nzokam, Christian Sieg, et al.
ACS Chemical Biology|October 10, 2017
Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14Marion Schuller, Kerstin Riedel, Ian Gibbs-Seymour, et al.
British Journal of Pharmacology|April 6, 2017
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approachAli Ryan, Elena Polycarpou, Nathan A Lack, et al.
Pageof 1